This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of California. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2025
Title: Innovations and Contributions of Weihong Liu
Introduction
Weihong Liu is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of immunology, particularly in the study of regulatory T cells. With a total of 4 patents, Liu's work has implications for the treatment of autoimmune disorders.
Latest Patents
One of Liu's latest patents focuses on the correlation between CD127 expression and the suppressive function of CD4+ Tregs. This invention provides methods for isolating CD127 immunosuppressive regulatory T cells, which can be greatly enriched for FoxP3. Additionally, it includes methods for expanding these isolated cells, pharmaceutical compositions of such cells, and their applications in treating autoimmune and other immune system-mediated disorders.
Career Highlights
Weihong Liu is affiliated with the University of California, where he conducts his research and develops innovative solutions in immunology. His work has garnered attention for its potential to advance therapeutic strategies in the medical field.
Collaborations
Liu has collaborated with notable colleagues, including Jeffrey A. Bluestone and Amy Putnam, who contribute to the research and development of his innovative ideas.
Conclusion
Weihong Liu's contributions to immunology through his patents and research at the University of California highlight his role as a key inventor in the field. His work continues to pave the way for advancements in the treatment of immune system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile